A New Technique Reveals How Immune Cells Locate Their Targets
MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins. The human body has…
Browsing tag
MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins. The human body has…
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
The same lightbulbs used in offices and public spaces can destroy coronaviruses and HIV, according to a new study from U of T Scarborough. Researchers…
Study suggests that different modes of transmission are associated with virus evolution. Variations in virus strains in different populations are associated with varying disease severity…
A COVID-19 risk variant inherited from Neanderthals reduces a person’s risk of contracting HIV by 27 percent. Some people become seriously ill when infected with…
A highly virulent variant of HIV-1 has been circulating in the Netherlands for the past few decades, researchers report. According to the new study, a…
New HIV variant with higher virulence and more damaging health impacts discovered in study led by the University of Oxford. As the ongoing coronavirus pandemic…
On December 20, 2021, the U.S. Food and Drug Administration announced its first approval of a long-acting HIV prevention medication. Developed by ViiV Healthcare, the…
A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to…
NIH scientists developed vaccine platform. An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice…
The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases. A common strategy to make vaccines more powerful…
This second untreated person living with HIV showed no evidence of intact HIV genomes in more than 1.5 billion blood and tissue cells analyzed. Ragon…
Different mechanisms suppressed the virus in each person. Research led by scientists at the National Institutes of Health has identified two distinct ways that people…
Proteins designed to focus immune attack on HIV-infected cells. Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert…
A team led by researchers at Weill Cornell Medicine and Children’s National Hospital has developed a unique pre-clinical model that enables the study of long-term…
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day….
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed…
Vaccines have curtailed the spread of several infectious diseases, such as smallpox, polio and measles. However, vaccines against some diseases, including HIV-1, influenza and malaria,…